Legal Representation
Attorney
M. Thomas Langan II
USPTO Deadlines
Next Deadline
1738 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-08-13)
Due Date
August 13, 2030
Grace Period Ends
February 13, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 13, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 13, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 28, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 28, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 8, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 19, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 22, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 22, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 22, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 20, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 20, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 20, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 19, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 7, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 11, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Intravenous solutions for replacing or maintaining electrolyte balance in animals
First Use Anywhere:
Mar 20, 2023
First Use in Commerce:
Mar 20, 2023
Additional Information
Pseudo Mark
LYTAJECT I V
Pseudo Mark
LYTAJECT 4
Pseudo Mark
LYTAJECT FOUR
Pseudo Mark
LYTAJECT INTRAVENOUS
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"IV"